scispace - formally typeset
P

Praveen K. Sappa

Researcher at Greifswald University Hospital

Publications -  16
Citations -  1238

Praveen K. Sappa is an academic researcher from Greifswald University Hospital. The author has contributed to research in topics: Bacillus subtilis & Promoter. The author has an hindex of 8, co-authored 16 publications receiving 1049 citations.

Papers
More filters
Journal ArticleDOI

Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in Bacillus subtilis

TL;DR: The transcriptomes of Bacillus subtilis exposed to a wide range of environmental and nutritional conditions that the organism might encounter in nature are reported, offering an initial understanding of why certain regulatory strategies may be favored during evolution of dynamic control systems.
Journal ArticleDOI

Large-scale reduction of the Bacillus subtilis genome: consequences for the transcriptional network, resource allocation, and metabolism.

TL;DR: An in-depth multi-omics analysis of the genome reduced strains revealed how the deletions affect the transcription regulatory network of the cell, translation resource allocation, and metabolism, and suggest the roads to further genome reduction to approach the final aim of a minimal cell in which all functions are understood.
Journal ArticleDOI

Efficient, Global-Scale Quantification of Absolute Protein Amounts by Integration of Targeted Mass Spectrometry and Two-Dimensional Gel-Based Proteomics

TL;DR: A novel approach for the absolute quantification of proteins at a global scale has been developed and its applicability demonstrated using glucose starvation of the Gram-positive model bacterium Bacillus subtilis and the pathogen Staphylococcus aureus as proof-of-principle examples.
Journal ArticleDOI

Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma.

TL;DR: The Kaplan–Meier survival analysis revealed a significant correlation of protein abundance of PRELP with postoperative survival of patients with PDAC, a potential new prognostic biomarker prolargin (PRELP).